发明名称 PARENTERAL PHARMACEUTICAL FORMULATION IN SUSPENSION, HAVING SUSTAINED RELEASE, IN LOW AND ULTRALOW DOSAGE, IN HORMONAL THERAPY IN THE CLIMACTERIC SYNDROME
摘要 Parenteral pharmaceutical formulation or composition, in suspension, having sustained release, containing suspended particles of estradiol and progesterone for hormonal replacement in female mammals in low and ultralow dosage; the formulation consists of an injectable suspension comprising particles of estradiol, particles of progesterone, a surfactant agent, an isosmotic agent, a thickening agent, and one or more preservation agents, wherein the estradiol is in particles having a size between 1 and 100 microns and the progesterone is in particles having a size between 1 and 100 microns, for application thereof in parenteral, intramuscular, subcutaneous or intradermal pharmaceutical form.
申请公布号 CA2781999(A1) 申请公布日期 2011.06.23
申请号 CA20102781999 申请日期 2010.12.14
申请人 TECHSPHERE, S.A. DE C.V. 发明人 ANGELES URIBE, JUAN;SAVOIR VILBOEUF, JOHN CLAUDE
分类号 A61K31/565;A61K9/16;A61K31/57;A61P5/30;A61P5/34 主分类号 A61K31/565
代理机构 代理人
主权项
地址